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Experimental allergic encephalomyelitis (EAE)  ~  has been widely studied as an animal 
model for determining the factors that participate in the pathogenesis of demyelinating 
diseases.  The evidence indicates that these disorders have an immunological basis,  in 
that injection of either nervous system tissue or protein and peptides isolated from this 
tissue, emulsified in complete Freund's adjuvant (CFA), induces EAE and immunoreac- 
tivity in laboratory animals. The main pathological feature of this disease is the acute 
vasculitis associated with perivascular myelin damage that results in the clinical signs of 
EAE (1-3). 
The antigen responsible for eliciting EAE exists within nerve tissue and may serve as 
an autoantigen causing an autoimmune response in the sensitized host. The capacity of 
an animal to react against its own cells may involve any of several possible cellular 
events:  (a)  an  absence of a  tolerant  state  to sequestered  antigens,  (b)  bypass of the 
tolerant  state  in  a  particular  cell  type,  or  (c)  a  modulation of a  normal  network of 
regulatory mechanisms. Recently, attempts have been made to gain some insight into the 
cellular parameters of certain autoimmune phenomena through determination of anti- 
gen-specific unresponsiveness  at  the  level  of the  thymus  (T)- and  bone  marrow  (B)- 
derived cells.  It has been  shown that  thyroiditis and production of autoantibodies to 
thyroglobulin in the mouse result from the stimulation of competent B cells by nonspe- 
cific activation ofT cells, thus bypassing the tolerant T cells (4). The presence of  B cells in 
the mouse (5) and peripheral blood lymphocytes in the human (6) that specifically bind 
syngeneic and homologous thyroglobulin, respectively, support the existence of compe- 
tent B cells for thyroglobulin. The inability of mice to respond to syngeneic thyroglobulin 
and the absence of antigen-binding lymphocytes (ABL) in the thymus of normal mice 
would be compatible with the hypothesis that unresponsiveness is maintained by the T 
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cell (5). These observations offer some insight into the possible mechanisms involved in 
the induction of autoimmunity in at least one model. It is therefore of importance to 
investigate the mechanism(s) of antigen recognition whereby EAE is produced since the 
cellular parameters of this disease appear to differ from those of experimental autoim- 
mune thyroiditis. 
Another important aspect of EAE is the ability to modify the disease by the treatment 
of animals with  nonencephalitogenic antigens, If the  central nervous system  (CNS) 
antigen is injected in a  nonencephalitogenic form, i.e.  either alone or incorporated in 
incomplete Freund's adjuvant (IFA), the disease produced as the result of a  previous 
injection of the encephalitogen in CFA is suppressed.  Several mechanisms have been 
implicated as being responsible for this effect, i.e. the existence of blocking antibody (7), 
immunologic tolerance (8), or the induction of suppressor T cells (9). 
This paper  is concerned with  the  immune  status  of T  and  B  cells to basic 
protein  of myelin  and  the  role  of these  cells  in  induction of EAE  in  rats. 
Furthermore, data are presented which deal with the nature of suppression of 
EAE by nonencephalitogenic forms of basic protein. 
Materials  and Methods 
Animals.  Female Lewis and Brown Norway (BN) rats (Microbiological Associates,  Bethesda, 
Md.) were used throughout the experiments. The animals were 4-wk old at thymectomy (Tx) and 
more than 6-wk old when immunized. Animals were maintained on Purina Laboratory Chow 
(Ralston Purina Co., St. Louis, Mo.) and water ad libitum. 
Myelin Basic Protein (BP).  Rat myelin BP was prepared by the method of Martenson et al. 
(10). Analysis  by polyacrytamide electrophoresis demonstrated only two bands associated with the 
16,000 and 12,000 molecular species previously  described for myelin  BP of the rat. Further analysis 
of 125I-labeled  preparations by polyacrylamide  gel electrophoresis demonstrated that only 5% of the 
lzsI content was not associated with the major bands of BP. Thus, it appears that the purity of these 
preparations was 95% or greater. 
Sensitization of Rats with Syngeneic BP.  Lewis rats were sensitized by inoculations into the 
rear foot pads of a mixture of 100 ~g BP in CFA containing 100 ~g Mycobacterium tuberculosis 
H37Ra  (Difco Laboratories, Detroit,  Mich.).  Control animals received  inoculations of normal 
saline emulsified in CFA. 
Evaluation  of EAE.  Animals were  examined daily for  clinical symptoms of EAE  which 
included evidence of weakness, paralysis, difficulty in righting, fecal impactation, loss  of tail 
tonicity, or ruffled fur. Rats were killed 14 days after inoculations. Sections of CNS tissue were 
stained with hematoxylin and eosin and examined microscopically for lesions of EAE. 
Detection of  Plaque-Forming Cells (PFC).  The plaquing procedure was a modification (11) of 
the method used by Jerne and Nordin (12) to assay direct PFC. Guinea pig serum served as the 
source of complement and rabbit anti-rat immunoglobulin  serum diluted 1:50 was added in order 
to detect indirect PFC as described previously (13). BP was conjugated to sheep  erythrocytes 
(SRBC) via a specific antibody  to SRBC by means of carbodiimide reagent (14). In brief, 200 mg of a 
freshly prepared aqueous solution of 1-ethyl-3-(3-dimethyl-aminopropyl)  carbediimide hydrochlo- 
ride (Story Chemical Co., Muskegon, Mich.) was added to the mixture of 20 mg of BP and 10 mg of 
IgG anti-SRBC in 1 ml of 0.15 M NaC1. The mixture was gently agitated at room temperature for 
30  min. The conjugated material was  then dialyzed against 0.15 M  NaC1 for  24  h  and the 
hemagglutinating  activity of the conjugated material was measured against SRBC. The BP-IgG 
conjugate was reacted with SRBC at a dilution of the BP-anti-SRBC IgG slightly higher than its 
hemagglutinating  titer. This allowed the specific antibody (conjugated to BP) to coat the erythro- 
cytes without causing hemagglutination. 
Iodination of BP.  Myelin BP was iodinated as described by McConahey and Dixon (15). For 
the autoradiographic and antigen-suicide  studies the sp act ranged from 40 to 75 and 200 to 400 
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antigen-binding capacity (ABC) assay,  the BP was labeled to asp  act of approximately 0.1-0.3 
~Ci/~g protein. 
Nitrogen Determinations.  Protein nitrogen determinations were performed by a  modification 
of the micro-Kjeldahl technique using the Technicon autoanalyzer (Technicon Instruments Corp., 
Tarrytown, N.  Y.) (16). 
Autoradiography  of ABL.  The  autoradiographic  method  employed  was  similar to  that de- 
scribed by Clagett and Weigle (5). In brief, thymuses and spleens were removed from the rats after 
exsanguination and single cell  suspensions were  made from each organ in minimal essential 
medium (MEM) (Grand Island Biological Co., Grand Island, N. Y.) supplemented with 10% fetal 
calf serum (FCS) and 0.1% sodium azide. 200 ~l of medium containing 20 ×  106 nucleated cells was 
added to 100 ng of 125I-BP and the cell suspensions were held at 4°C for 30 min. To remove unbound 
~25I-BP from the cell suspension, each cell preparation was layered over 7 ml of FCS and centri- 
fuged at 200 g  for 10 min. This step was repeated three times.  Cell smears were made on pre- 
cleaned slides, air-dried and fuxed, and the slides were immersed in NTB-2 (Eastman Kodak Co., 
Rochester, N. Y.). Exposure times varied from 7 to 14 days. The slides were developed and stained 
with Giemsa, and in each preparation at least 105 cells were scanned for the presence of grains. 
In blocking experiments with unlabeled BP, the cell suspensions were mixed first with a 100- to 
1,000-fold excess of BP diluted in MEM and incubated at 4°C for 30 min. The cell suspensions were 
then incubated with 125I-BP for 30 min at 4°C.  In blocking experiments with antisera,  the cell 
suspensions (200 ~1) were incubated with an equal volume of appropriately diluted antisera for 2 h 
at 4°C before the addition of ~2'~I-BP. 
Antigenic Suicide of  Normal Bone Marrow and Thymus Cells.  Syngeneic rat BP was iodinated 
with  ~2'~I at  a  specific activity of 200-400  ~Ci/~g protein as described previously  (15).  Normal 
thymuses  and  bone  marrow  were  collected  from  6-  to  8-wk-old  Lewis  rats.  The  cells  were 
suspended in MEM with 10% FCS at 5 ×  107 cells/ml and were incubated separately with ~25I-BP at 
a ratio of approximately 3 ~g/10  H  cells (5). The cell suspensions were held at 4°C for 5 h. Then, the 
cells (5 ml) were layered over 20 ml FCS and centrifuged at 200 g  for 15 min in the cold, and the 
process  was  repeated  twice.  After  the  final  wash,  the  treated  cells  together  with  untreated 
lymphocytes from the other cooperating cell line were suspended in MEM and injected intrave- 
nously into lethally (900 R) irradiated, Tx recipients. A control group in which cold BP was used 
instead of iodinated antigen was included.  4-6 days after reconstitution, the rats were injected 
with  BP-CFA  as  previously  described.  Anti-thymocyte  serum  was  prepared  and  titrated  as 
described previously (17). 
Quantitation of  Antibody to Rat BP.  Antibody to BP was determined by the sodium sulphate 
method described by Day and Wexler (18).  Results are reported as micrograms of BP bound per 
milliliter of serum. Background values obtained in the sara of unimmunized rats were subtracted 
but were usually lower than 1-2 ~g of BP/ml of serum. 
Suppression  with Soluble BP.  Rats  were  sensitized with  100  ~g  of BP-CFA.  Suppression 
treatment was started 3 days later with 800 ~g of BP by intradermal (i.d.) injection. The same 
treatment was repeated 6, 9, and 12 days after the sensitizing injections. 
Suppression with BP in IFA.  3 days after rats were injected with 100 ~g of BP-CFA, they were 
injected with 100 ~g BP in IFA for suppression of EAE as previously described (9). A total of eight 
i.d. injections were given over a  2 wk period. 
Adoptive Transfer Experiments to Study the Role of Suppressor Cells.  For adoptive transfer 
experiments, donor rats were either treated with the soluble BP or BP-IFA as described above. 
Spleens and lymph nodes collected from both normal rats and rats injected with BP were excised 
separately into balanced salt solution (BSS). The single cell suspensions were centrifuged at 200 g 
for 10 min and washed three times with BSS.  Viabilities were determined by trypan blue dye 
exclusion. Cells were combined according to the particular protocol and suspended in 1 ml of BSS. 
The cells were adoptively transferred into Tx, irradiated (900 R) rats by intravenous injection via 
the lateral tail vein. Challenges with BP-CFA were performed on the day of the transfer or 4-6 
days later. Rats were examined daffy for symptoms of EAE as previously described and sacrificed 
14 days after challenge. 
Statistical Analysis.  The  significancy in  the  number of ABL  found  in  the  nonimmunized 
control rats and the ABL observed after different experimental treatments was determined by the 
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TABLE  I 
Frequency of  ABL to BP in Spleen and Thymus of  Normal Lewis and 
BN Rats 
607 
Amount of ~5I  Source of normal 
Rat strain  ABL/105 cells 
BP  lymphoid cells 
ng 
100  Thymus  Lewis  8 
100  Thymus  BN  0 
100  Spleen  Lewis  17 
100  Spleen  BN  11 
Results 
Autoradiographic  Detection  of lz5I-BP-Binding  Lymphocytes  in  Unimmu- 
nized Rats.  The frequency of thymus and spleen cells from unprimed Lewis 
rats that bound 125I-labeled syngeneic BP is shown in Table I. When thymus 
cells were incubated with 125I-BP, 8/105 cells were positive, whereas there were 
17/105 ABL in the spleen cells. On the other hand, thymus cells from BN rats did 
not bind ~25I-BP. However, a normal complement of ABL was detected in their 
spleen cells. This finding, together with the inability of the anti-thymus serum 
to inhibit the ABL in the spleen, indicates the absence of ABL in T cells of BN 
rats. 
Antigen-Suicide of Normal Thymus and Bone Marrow Cells by IzsI-Labeled 
Syngeneic  BP.  The results obtained by determining ABL indicated the pres- 
ence of immunocompetent  T and very likely B cells in the Lewis strain of rats. 
Therefore, it  was of interest to  determine if such cell populations could be 
rendered unresponsive by  "suicide" with  syngeneic ~z~I-BP of high  specific 
activity. The data in Table II clearly show the following:  (a) Normal thymus 
cells in the presence of B cells treated with heavily iodinated ~zSI-BP were able, 
when transferred to  Tx  irradiated rats,  to  support  the  sensitization of the 
adoptively transferred animals and the development of EAE. These animals, 
however, were unable to produce PFC to BP. Despite the inability to form PFC 
to BP,  they mounted a  humoral immune response to an unrelated antigen, 
namely, burro erythrocytes (BRBC); (b) When thymus cells were suicided and 
transferred together with normal bone marrow cells to Lewis rats, the animals 
could not be sensitized when injected with BP-CFA. This inability to respond 
was manifested by an  absence of both EAE and PFC  to BP.  However, the 
animals formed PFC to a thymus-dependent antigen, i.e. BRBC,  showing the 
specificity of the cells killed by the radioiodinated antigen; (c) Normal thymus 
cells transferred together with thymus cells which were previously suicided and 
normal bone marrow cells, however, restored the capacity of rats to become 
sensitized  with  BP-CFA,  resulting in  both  EAE  and  PFC  to  BP;  (d)  The 
treatment of both  cell populations by radioiodinated antigen prevented the 
induction of EAE and the formation of PFC to BP, but not to the BRBC; (e) The 
transfer of thymus cells which were previously treated with cold BP and normal 
bone marrow cells to rats resulted when sensitized with BP-CFA, in the develop- 
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TABLE II 
Antigen Suicide of Thymus and Bone Marrow Cells by ~2~I-Labeled Syngeneic BP 
Cells transferred  EAE*  PFC to: 
Recipients sen- 
sitized  with  Histologi.  BP$  BRBC§  B cells  T cells  Clinically  cally 
250 x I0  ~ Normal bone  200 ×  l0  s Normal thy-  BP-CFA  i0/I0  I0/I0  2{)  8,742 
marrow  mocytes 
250 ×  10  ~ Bone marrow  200  ×  10  ~ Normal  thy-  BP-CFA  10/10  10/10  0  11,196 
and ~2~I BP  mocytes 
250  ×  10  ~ Normal bone  200  ×  10  ~  Thymocytes  BP-CFA  0/5  0/5  0  17,763 
marrow  and ~z'~I  BP 
250  ×  10  ~ Normal bone  200  ×  10  ~  Thymocytes  BP-CFA  10/10  10/10  28  16,240 
marrow  and  ~2~I BP  +  200  × 
10  ~  normal  thyrno- 
cy'tes 
250 ×  106 Bone marrow  200  ×  10  ~  Thymocytes  BP-CFA  0/10  0/10  0  14,706 
and ~2~I  BP  and  ~z~!  BP 
250  ×  10  ~ Normal bone  200  x  10  ~  Thymocytes  BP-CFA  9/10  10/10  31  15,322 
marrow  and cold BP 
250 ×  10  ~ Bone marrow  None  BP-CFA  0/10  0/10  0  75 
and J~I  BP 
250 x 106 Normal bone  None  BP-CFA  0/4  0/4  0  0 
marrow 
250 ×  10  e Bone marrow  200  ×  1~  Normal  thy-  CFA  0/5  0/5  0  16,962 
and 12~I BP  mocytes 
250 x  106 Bone marrow  200  ×  10  ~ Normal  thy-  CFA  0/5  0/5  0  llT ~ 
and ~=~I  BP  mocytes 
* Positive/total. 
PFC/106 popliteal lymph node cells. 
§ PFC/spleen. 
" Background to BRBC. Rats were not immunized with BRBC. 
either treated or not treated with the radioiodinated  antigen,  were not sensi- 
tized by BP-CFA and did not form PFC to a  thymus-dependent antigen,  i.e., 
BRBC.  In control groups transferred with both normal T and B cells,  sensitiza- 
tion was represented by the appearance  of both EAE and PFC to BP.  Results 
from control rats given CFA alone eliminated the possibility that CFA caused 
the sensitization. 
Suppression ofEAE.  In the two experiments shown in Table III, Lewis rats 
treated  with  BP  without adjuvant and subsequently  sensitized with  BP-CFA 
were unable to develop EAE. However, they did form similar levels of antibodies 
to BP as the nonsuppressed group in which EAE was manifest.  On the other 
hand, control rats receiving only the BP (without CFA) developed neither EAE 
nor antibodies to BP. 
Similar  results were  obtained when animals  were  injected with  BP in IFA 
after sensitization with BP-CFA (Table IV) in that none of the treated animals 
that received a prior injection of BP-CFA developed EAE. In this case, however, 
antibodies were produced in all groups including the group which received BP in 
IFA. 
Determination  of Suppressor  Cells in the Spleens and Lymph Nodes of Lewis 
Rats Protected Against EAE  by Immunosuppressive  Treatment.  Attempts 
were made to determine how treatment with the soluble BP in rats sensitized 
with BP-CFA caused suppression. Adoptive transfers were performed to detect 
suppressor T cells in the spleen cells as well as in the lymph node cells (LNC) of 
rats pretreated  with  either  BP  alone  or BP  in  IFA,  as  indicated  before,  and LIBRADO  ORTIZ-ORTIZ  AND  WILLIAM  O.  WEIGLE  609 
TABLE  III 
Experimental Suppression  of  EAE in Lewis Rats by Intradermal Injection of  Soluble BP 
from Spinal Cord* 
EAE§ 
Group  Injected  Sensitized with$  Serum 
Exp. no.  no.  with  Histologi-  ABC  'r 
Clinically  cally 
1  BP  -  0/5  0/5  0.4 
2  BP  BP-CFA  0/5  1/5  4.2 
3  -  BP-CFA  4/4  4/4  5.8 
1  BP  -  0/5  0/5  0 
2  BP  BP-CFA  0/5  2/5  3.9 
3  -  BP-CFA  3/5  5/5  4.0 
* Rats received four i.d. injections of soluble BP (800 tLg each) every 3 days. 
$ Rats were sensitized with 100 tLg of BP in CFA. Group 2 received the initial dose of soluble BP 3 
days after sensitization. 
§ Positive/total. 
rl  Values reported represent micrograms of BP bound per milliliter of serum. Determinations were 
done 14 days after sensitization. 
TABLE  IV 
Experimental Suppression  of EAE in Lewis Rats by Injection  of BP in IFA * 
EAE§ 
Group  Injected with  Sensitized with$  Serum 
no.  Clinically  Histologi-  ABC  ~' 
cally 
1  BP-IFA  -  0/5  0/5  2.4 
2  BP-IFA  BP-CFA  0/5  0/5  3.6 
3  -  BP-CFA  5/5  5/5  4.7 
* Rats received eight subcutaneous injections of BP (100  ~g each) in IFA in a  2-wk period. 
Rats were sensitized with 100  t~g of BP in CFA. Group 2 received the initial dose of BP-IFA 3 
days after sensitization. 
§ Positive/total. 
'~  Values reported represent micrograms of BP bound per milliliter of  serum. Determinations were 
done 14 days after sensitization. 
combined with either LNC or spleen cells of untreated rats as outlined in Table 
V. No protection was afforded by the spleen cell population of suppressed rats, 
when mixed with normal LNC. This group and the group receiving only normal 
spleen and LNC behaved similarly in the capacity to develop EAE and to form 
antibodies to BP aider sensitization with BP-CFA. The same result was observed 
when LNC from suppressed rats were combined with spleen cells obtained from 
unimmunized rats. 
The results of adoptive transfers of cells obtained from animals  immunized 
with BP-IFA were similar. Again, no suppressor activity could be demonstrated 
in either the spleen cell or LNC populations. 
Determination of  ABL in Thymus and Spleen Cells of  Rats Protected Against 
EAE  by Immunosuppressive  Treatment.  Cell  suspensions  from  Lewis  rats 
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TABLE  V 
Effect of Inoculating Lymphoid Cells from Immunosuppressed Rats Together  with 
Lymphoid Cells from Unimmunized Animals on the Induction of EAE 
Source of cells*  EAE§ 
Group  Suppressive  Spleen  Lymph node  Sensitized  Histo-  Serum 
no.  treatment  with$  Clini-  ABC  ~r 
cally  logi- 
cally 
1  None  Normal  Normal  BP-CFA  9/10  10/10  4.4 
2  BP  Suppressed  Normal  BP-CFA  7/9  9/9  3.9 
3  BP  Normal  Suppressed  BP-CFA  5/5  5/5  4.5 
4  BP-IFA  Suppressed  Normal  BP-CFA  4/5  5/5  5.0 
5  BP-IFA  Normal  Suppressed  BP-CFA  6/6  6/6  5.0 
6  None  Normal  Normal  CFA  0/5  0/5  0 
* Single cell suspensions from either spleen cells or LNC from Lewis rats protected against EAE 
by injection of encephalitogenic BP from rat spinal cord, were mixed with either spleen or LNC 
from normal rats and transferred into previously Tx, irradiated (900 R) rats. 
$ Animals were sensitized with BP emulsified in CFA. 
§ Positive/total. 
" ABC determinations were done at sacrifice 14 days after sensitization with BP-CFA. Values 
represent micrograms of BP bound per milliliter of serum. 
TABLE  VI 
Effect of Suppression of EAE on ABL in Lewis Rats 
ABL per 10  ~ cells 
Rats injected with* 
Spleen  Thymus 
BP-CFA  125  16 
BP-CFA and BP*  55  4 
BP§  11  0 
* Organs for study of ABL were taken from the experimental animals previ- 
ously shown in Table V. 
$ The reduction in the number of ABL is significant when compared with the 
group treated with BP-CFA alone; i.e., spleen: P < 0.01; thymus: P < 0.01. 
§ The reduction in the number of ABL in  the thymus is significant when 
compared with the untreated control group (Table I), P  <  0.01. 
studies. For this purpose, rats were sacrificed 14 days ai~r  challenge with BP- 
CFA,  and  ABL  were  determined  in  the  thymuses  and  spleens  as  described. 
Table VI shows that injection of rats with soluble BP diminished to a  significant 
level the number  of ABL present  after a  subsequent  challenge with  BP-CFA. 
The decrease was greater in the thymus  cell population, although the number  of 
ABL  also  decreased  in  the  spleen  cells.  On  the  other  hand,  the  group  that 
received the  BP,  but  was  not  challenged  afterward,  showed  no  thymus  cells 
binding  BP  (P  <  0.01)  and  a  diminished  number  of ABL  in the  spleen cells, 
when  compared  to those from unimmunized  rats  (17/105 cells). Experiments  in 
which ABL were blocked with cold BP showed no differences when compared to 
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Discussion 
The results presented above showed that T cells were the only cells required 
for the induction of EAE after immunization with BP-CFA, albeit beth T and B 
cells contained specific receptors capable of recognizing syngeneic BP. ABL to 
BP have been previously reported in the spleens of guinea pigs immunized with 
BP-CFA (20). Conversely, no significant ABL have been found in rats sensitized 
with BP-CFA  (20). The low numbers of ABL to BP found in thymuses and 
spleens of normal rats in the present study could explain the previous failures of 
others to detect them (20). In addition, the experimental conditions used in the 
present studies, i.e.  higher specific activity of the ~25I-BP, amount of 125I-BP 
added to the reaction, and time of exposure, also favored the detection of ABL to 
BP in this model. 
The relationship between ABL detected in vitro and their role in initiating the 
induction of EAE in vivo was established with antigen-suicide experiments (21- 
23) involving elimination of specific T- and B-cell functions by treatment with 
heavily iodinated (125I) BP.  Thus,  no EAE was observed when T  cells were 
suicided with high specific activity ~I-BP and transferred into rats with immu- 
nocompetent B cells (B rats) which were then challenged with the BP in CFA, 
indicating that pretreatment with labeled BP eliminated specific T cells and 
thus abolished cell-mediated immunity to this neuroantigen. In addition, the 
treatment of T cells with the 125I-labeled antigen specifically inactivated the T- 
cell collaborative effect with the B cell for the formation of antibody to BP, but 
not for the nonspecific anti-BRBC response. Furthermore, supplementing the 
antigen-suicided thymus cell  inoculum with  normal thymus cells effected a 
reversal of this inactivation, i.e., the appearance of clinical EAE and antibody 
formation to BP.  In contrast to the inhibition of EAE by specific suicide of T 
cells, EAE and PFC to BP developed in response to BP-CFA injection in Tx, 
irradiated rats that were reconstituted with thymocytes  previously treated with 
cold BP and normal bone marrow cells. In addition, EAE was observed aider BP- 
CFA challenge in Tx, irradiated rats that were transferred with normal T cells, 
and bone marrow which had previously been suicided in vitro with '25I-BP of 
high specific  activity. The absence of antibody formation to BP in this group 
strongly indicated that suicide of specific antibody precursor cells did not alter 
the induction of EAE by the neuroantigen. In this regard, there have been 
numerous reports concerning the possible role of antibody in EAE. In agreement 
with the above observation, attempts to induce EAE by injection of sera ob- 
tained from sensitized animals have been unsuccessful (24-26). In addition, the 
disease may be induced regularly in bursectomized chickens (27). Furthermore, 
it has been reported that sera from animals with EAE have a protective effect on 
the development of EAE  after injection of BP-CFA  (28). The antibody may 
protect by interfering either with the sensitization of lymphocytes by the CNS 
antigen or with the activity of ABL or, less likely, by reacting with target tissue 
in the brain  and thereby protecting against sensitized lymphocytes or their 
products. It is also possible that antibodies may participate in the progression of 
the  disease  initiated  by  sensitized  cells.  The  present  results  indicate  that 
whether antibodies protect from or enhance EAE,  they are not a  necessary 
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It has been postulated that some autoantigens that circulate in low concentra- 
tions maintain unresponsiveness in specific populations of T but not in B cells 
(29-30). For example, thyroglobulin has been shown to circulate in sufficient 
concentrations to maintain unresponsiveness in T cells but not in B cells (31). 
Induction of tolerance to heterologous antigen in  T  cells requires extremely 
small amounts of tolerogen as compared to the relatively large amounts re- 
quired for B-cell tolerance (29, 31). The demonstration by Clagett and Weigle (5) 
that specific unresponsiveness to autologous thyroglobulin exists in the T cells 
while the B cells remain responsive confirms this dichotomy  with self-antigens. 
Therefore, B cells can recognize both cross-reacting and self-antigens on heterol- 
ogous thyroglobulin, whereas the T-cell  population is capable of recognizing 
only the unrelated determinants on these cross-reacting antigens. This is an 
important consideration in EAE since most work has been done with allogeneic 
or xenogeneic rather than syngeneic BPs. The available data, for the most part, 
indicate that  EAE  is  produced primarily,  if not  solely,  by  a  cell-mediated 
response to BP, strongly implicating T cells (32-35). In contrast to the immune 
status ofT and B cells to thyroglobulin, apparently there is no unresponsiveness 
in the T cells to BP which prevents the natural induction of EAE. In fact, the 
data with both ABL and the suicide experiments can only be explained if both T 
and B cells specific for BP are immunocompetent. 
The importance of the antigen receptor on T cells as a mechanism of antigen 
recognition and the participation of these cells in EAE could explain the fact 
that BN  rats,  which according to  the present studies do  not contain T-cell 
receptors for BP, have been shown by several investigators to resist sensitiza- 
tion with BP-CFA (36-39). Furthermore, Pitts et al. (40) obtained antibodies but 
not EAE after immunizing BN rats with BP-CFA and pertussis vaccine, an 
adjuvant known to stimulate B-cell proliferation (41). The latter results further 
support the presence of unresponsiveness at the T-cell but not B-cell level in the 
BN rat.  However, EAE  could be  induced in  these rats when more complex 
neural antigens were used (36), which might bypass the specificity of tolerant T 
cells.  The latter model may resemble the immune status of T and B cells in 
thyroiditis, i.e., unresponsiveness at the T-cell level can be overcome by giving a 
heterologous antigen (42). 
Another mechanism postulated in the control of autoimmune reactions is that 
of regulation by suppressor T cells. Our results do not support a role of suppres- 
sor T cells in inhibiting the induction of EAE by injection of  nonencephalitogenic 
BP.  It  was  reported  that  thymocytes from  bovine  gamma  globulin  (BGG) 
inoculated rats could, upon adoptive transfer to normal rats, specifically sup- 
press both cell-mediated and antibody responses to BGG (43). Recently a popula- 
tion of suppressor cells, present in the lymph nodes and stimulated by treatment 
of rats with BP in IFA, was thought to exert control over the development of 
EAE in rats (9). In the present studies, adoptive transfer experiments provided 
no evidence for the presence of suppressor cells in either the spleens or lymph 
nodes of rats  protected against EAE  by treatment with BP  either alone or 
incorporated  in  IFA.  In  this  respect,  the  present  results  differ from  those 
previously reported (9). These differences  could be explained in that in the above 
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used by others (9), and that the techniques differed. Suppressor activity has 
been shown to be lost with age in New Zealand mice (44, 45), and this loss was 
associated with the spontaneous induction of auteimmune disease. Although the 
present data suggest that suppressor activity is not involved in the abrogation of 
EAE afforded by nonencephalitogenic BP, these observations cannot be inter- 
preted to mean that suppressor T cells play no role in regulation of autoimmune 
phenomena similar to that observed in New Zealand mice. 
Although circulating antibody has been postulated to be responsible for the 
inhibition of the cellular immune response which presumably mediates EAE 
(46), such antibody does not appear to be involved in the inhibition of EAE by 
injection of BP without adjuvant or BP in IFA as shown in the present paper. 
First, rats injected with BP-IFA failed to develop EAE when also challenged 
with BP-CFA, but developed circulating antibodies to BP at the same level as 
rats injected only with the BP-CFA. Similarly, rats protected by injection of BP 
without adjuvant develop a normal level of circulating antibody when injected 
with BP-CFA. In this latter experiment, since the BP-CFA was given before (3 
days) the suppressing injections of either BP-IFA or BP without adjuvant, the 
production of antibody in the suppressed group is not unexpected. Thus, effector 
T cells could well be suppressed although B cells have differentiated  to the stage 
where T-cell help is no longer required for antibody synthesis. This possibility is 
compatible with  the  presence of a  decreased number of ABL to  BP  in  the 
suppressed group despite a normal level of circulating antibody. The failure to 
develop EAE but not antibody production in the suppressed rats is apparently 
the result of inhibition of an effecter  T-cell population after the precursor B cells 
have been committed and no further T help is required. 
Summary 
Although both  the  T  and  B  cells of the  Lewis rat  have  immunoglobulin 
receptors for basic protein (BP) of myelin, and both cell types are required for 
antibody production to BP, the present results demonstrate that the T cells are 
the only cells required for the induction of experimental allergic encephalomye- 
litis  (EAE). Both EAE and anti-BP were readily induced in thymectomized, 
irradiated Lewis rats reconstituted with normal thymus and bone marrow cells 
and challenged with BP in complete Freund's adjuvant. If  the thymus cells were 
first treated with BP heavily labeled with ~25I so as to eliminate (suicide) specific 
T cells, the recipients neither develop EAE nor produce antibody to BP. On the 
other hand, if the thymus cells were untreated and the specific B cells of bone 
marrow were eliminated by treatment with I~SI-BP, EAE was not inhibited, 
although no antibody was produced. These results strongly suggest that the T 
cell is responsible for the induction of EAE although both the T and B cells are 
competent to respond to BP. 
Evidence was presented which suggests that neither suppressor T cells nor 
circulating antibody are involved in the inhibition of EAE by injection of Lewis 
rats with nonencephalitogenic  preparations of BP. The immune status of T and 
B cells of the Lewis rat to BP was compared with the immune status of these 
cells in  other species to  thyroglobulin, where only the  B  cells appear to be 
competent. In  this  context,  Brown Norway rats,  which are resistant to  the 614  CELLULAR  EVENTS  IN  EXPERIMENTAL  ALLERGIC  ENCEPHALOMYELITIS 
induction of EAE, also appear to lack T cells reactive to BP, although competent 
B  cells are present. 
Received for publication 14 May 1976. 
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